These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33059322)

  • 21. Development and Optimization of Dual Drugs (Isoniazid and Moxiflox-acin) Loaded Functional PLGA Nanoparticles for the Synergistic Treatment of Tuberculosis.
    Moin A; Raizaday A; Hussain T; Nagshubha B
    Curr Drug Deliv; 2016; 13(7):1034-1052. PubMed ID: 27138300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
    Liu J; Gong T; Wang C; Zhong Z; Zhang Z
    Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interception of host angiogenic signalling limits mycobacterial growth.
    Oehlers SH; Cronan MR; Scott NR; Thomas MI; Okuda KS; Walton EM; Beerman RW; Crosier PS; Tobin DM
    Nature; 2015 Jan; 517(7536):612-5. PubMed ID: 25470057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nostril infection due to Mycobacterium marinum in an immunocompetent host.
    Khosrovaneh A; Briski LE; Jankowski E; Khatib R
    Scand J Infect Dis; 2002; 34(12):929-31. PubMed ID: 12587630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rifampicin-resistant Mycobacterium marinum infection in a newly diagnosed HIV-1 individual.
    Seneviratne K; Herieka E
    Int J STD AIDS; 2013 Jan; 24(1):75-7. PubMed ID: 23512514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of solid lipid nanoparticles as drug carriers for levothyroxine sodium with in vitro drug delivery kinetic characterization.
    Rostami E; Kashanian S; Azandaryani AH
    Mol Biol Rep; 2014 May; 41(5):3521-7. PubMed ID: 24515386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Murine Mycobacterium marinum Infection as a Model for Tuberculosis.
    Lienard J; Carlsson F
    Methods Mol Biol; 2017; 1535():301-315. PubMed ID: 27914088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium marinum infection complicated by anti-tumour necrosis factor therapy.
    Ramos JM; García-Sepulcre MF; Rodríguez JC; Padilla S; Gutiérrez F
    J Med Microbiol; 2010 May; 59(Pt 5):617-621. PubMed ID: 20133411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and characterization of solid lipid nanoparticles loaded with frankincense and myrrh oil.
    Shi F; Zhao JH; Liu Y; Wang Z; Zhang YT; Feng NP
    Int J Nanomedicine; 2012; 7():2033-43. PubMed ID: 22619540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity.
    Baig MS; Ahad A; Aslam M; Imam SS; Aqil M; Ali A
    Int J Biol Macromol; 2016 Apr; 85():258-70. PubMed ID: 26740466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of Antimycobacterial Activity of Rifampicin Using Mannose-Anchored Lipid Nanoparticles against Intramacrophage Mycobacteria.
    Mistry N; Bandyopadhyaya R; Mehra S
    ACS Appl Bio Mater; 2022 Dec; 5(12):5779-5789. PubMed ID: 36441965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of solid lipid nanoparticles (SLNs) of lopinavir using hot self nano-emulsification (SNE) technique.
    Negi JS; Chattopadhyay P; Sharma AK; Ram V
    Eur J Pharm Sci; 2013 Jan; 48(1-2):231-9. PubMed ID: 23153618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of lipid matrix on repaglinide-loaded solid lipid nanoparticles for oral delivery.
    Rawat MK; Jain A; Mishra A; Muthu MS; Singh S
    Ther Deliv; 2010 Jul; 1(1):63-73. PubMed ID: 22816120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation, characterization and in vitro cytotoxicity of Fenofibrate and Nabumetone loaded solid lipid nanoparticles.
    Kumar R; Singh A; Sharma K; Dhasmana D; Garg N; Siril PF
    Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110184. PubMed ID: 31753394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Entrapment of multiple anti-Tb drugs in microemulsion system: quantitative analysis, stability, and in vitro release studies.
    Mehta SK; Kaur G; Bhasin KK
    J Pharm Sci; 2010 Apr; 99(4):1896-911. PubMed ID: 19894276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
    Song A; Zhang X; Li Y; Mao X; Han F
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyurethane-functionalized starch nanocrystals as anti-tuberculosis drug carrier.
    Desai SK; Mondal D; Bera S
    Sci Rep; 2021 Apr; 11(1):8331. PubMed ID: 33859215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis.
    Rawal T; Parmar R; Tyagi RK; Butani S
    Colloids Surf B Biointerfaces; 2017 Jun; 154():321-330. PubMed ID: 28363192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microwave-assisted formulation of solid lipid nanoparticles loaded with non-steroidal anti-inflammatory drugs.
    Shah RM; Eldridge DS; Palombo EA; Harding IH
    Int J Pharm; 2016 Dec; 515(1-2):543-554. PubMed ID: 27789371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis.
    Pandey R; Zahoor A; Sharma S; Khuller GK
    Tuberculosis (Edinb); 2003; 83(6):373-8. PubMed ID: 14623168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.